Target intelligence / Profile preview

Arterial lumen of tumor-feeding vessels

Molecular classification
Other
01

Overview

The arterial lumen of tumor-feeding vessels refers to the internal space of the arteries that provide the primary blood supply, oxygen, and nutrients to a malignant tumor. In clinical practice, this anatomical site is not a molecular target like a receptor or enzyme, but rather a physical target for interventional oncology procedures such as transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) [PMID: 11830197]. By navigating microcatheters into these lumens, clinicians can deliver high doses of chemotherapy or radioactive isotopes directly to the tumor while minimizing systemic toxicity [PMID: 27034148]. This approach is particularly effective for hypervascular tumors, such as hepatocellular carcinoma, which derive the majority of their blood supply from the hepatic artery rather than the portal vein [PMID: 21544803]. The therapeutic goal is to induce tumor necrosis through a combination of localized cytotoxic insult and ischemia caused by the physical blockage of the lumen with embolic materials. Consequently, the lumen acts as a critical gateway for locoregional therapy rather than a biological trigger for signal transduction.

Other names
Tumor-feeding arteryTumor-supplying vesselTumor vasculature lumenFeeding arteryTumor-related arterial lumen
02

Mechanism of action

The arterial lumen serves as a conduit for the direct delivery of cytotoxic drugs or embolic agents via catheterization to induce high local drug concentrations and tumor ischemia.

03

Biological functions

Blood supplyNutrient transportOxygen deliveryWaste removal
04

Disease associations

CancerHepatocellular carcinomaHypervascular tumorsMetastatic liver disease
05

Safety considerations

Non-target embolizationPost-embolization syndromeVessel dissectionArterial thrombosisOff-target tissue ischemiaArterial perforation
06

Interacting drugs

Doxorubicin

6 more in the full profile.

07

Biomarkers

Angiographic hypervascularityVascular endothelial growth factor (VEGF) levelsContrast enhancement on CT/MRI

Beyond the preview

Go deeper on Arterial lumen of tumor-feeding vessels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arterial lumen of tumor-feeding vessels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call